MedTrace Logo

Systemic Adverse Effects After Osteopathic Treatment and Vitamin C

NCT06102577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2023-10-31

No results posted yet for this study

Summary

The goal of this triple-blind randomized clinical trial is to learn about systemic adverse effects in first visit patients who attend an osteopathic medicine center in Barcelona. The main question it aims to answer are:

• Check if there is a relationship between taking vitamin C and the reduction in the appearance of systemic adverse effects after osteopathic treatment (24-72 hours) First-visit patients, at the end of treatment, are asked to enter the study. If they accept, they are administered 1g. of vitamin C, or 1g. placebo or nothing.

If there is a comparison group: Researchers will compare placebo group, control group and intervention group to see if there is a relationship between taking vitamin C and the appearance of systemic adverse effects\].

Conditions

  • Adverse Effects
  • Ascorbic Acid
  • Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

1gr. Vitamine C

Take 1g. of vitamin C at the end of an osteopathic manual treatment

OTHER

1gr Placebo

ake 1g. of placebo at the end of an osteopathic manual treatment

OTHER

control group

control

Sponsors & Collaborators

  • Centre Medicina Esportiva i Osteopatia, Spain

    lead OTHER

Principal Investigators

  • Rafael Merino Solis, MD · CMosteoesport

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-06-30
Completion
2023-07-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06102577 on ClinicalTrials.gov